drugset / Trial / NCT07624227

The Impact of Cobenfy Maintenance on Cocaine's Effects

NCT07624227

Phase 1/2 Not yet recruiting 32 enrolled University of Kentucky
RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this clinical trial is to learn if Cobenfy influences the effects of cocaine in people with cocaine use disorder. This trial will also provide information about the safety and tolerability of combining Cobenfy and cocaine. Researchers will compare Cobenfy to a placebo (a look-alike substance that contains no drug) to see if Cobenfy is a safe, tolerable and effective at blocking cocaine's effects in participants with cocaine use disorder. Participants will: * Participate in an 11-day inpatient trial * Take Cobenfy or placebo twice per day. * Participate in experimental sessions to test the effects of Cobenfy (or placebo) on the response to cocaine and cocaine self-administration.

Timeline

Start
2026-08-01
Primary completion
2032-06-30
Completion
2032-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Trospium Small molecule 20 mg
Subject Xanomeline Small molecule 100 mg